Roberto Alcázar-Arroyo

Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary.

A. Sicras-Mainar, N. Manito, B. Palacios, 2021, Endocrinologia, diabetes y nutricion.

Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary

A. Sicras-Mainar, N. Manito, B. Palacios, 2021, Endocrinología, Diabetes y Nutrición.

What is the role of expanded hemodialysis in renal replacement therapy in 2020?

R. Pérez-García, Patricia de Sequera-Ortiz, Roberto Alcázar-Arroyo, 2021, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study

S. Pizarro, P. López-Sánchez, J. Portolés, 2021, Clinical kidney journal.

Hemodialysis Centers Guide 2020

M. Arenas, M. Arias-Guillén, F. Maduell, 2021, Nefrología (English Edition).

Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020

A. Ortíz, E. González-Parra, M. Fernández-Lucas, 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain.

Roberto Alcázar-Arroyo, M. Crespo-Leiro, Jordi Bover, 2024, Nefrologia.